ID   UBP15_HUMAN             Reviewed;         981 AA.
AC   Q9Y4E8; Q08AL5; Q9H8G9; Q9HCA6; Q9UNP0; Q9Y5B5;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   12-FEB-2003, sequence version 3.
DT   10-MAY-2017, entry version 171.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 15;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 15;
DE   AltName: Full=Ubiquitin thioesterase 15;
DE   AltName: Full=Ubiquitin-specific-processing protease 15;
DE   AltName: Full=Unph-2;
DE   AltName: Full=Unph4;
GN   Name=USP15; Synonyms=KIAA0529;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RA   Kim K.I., Nagase T., Chung C.H.;
RT   "Identification and characterization of a new human deubiquitinating
RT   enzyme Unph4.";
RL   Submitted (NOV-1998) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [3]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hair follicle dermal papilla;
RA   Kim M.K., Kim Y.H., Seo J.M., Lee H.M., Chung H.J., Sohn M.Y.,
RA   Hwang S.Y., Im S.U., Jung E.J., Lee J.H., Kim J.C.;
RT   "A catalogue of genes in the human dermal papilla cells as identified
RT   by expressed sequence tags.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-21; 475-482 AND 924-932, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary carcinoma;
RA   Bienvenut W.V., Matallanas D., Cooper W.N., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-981 (ISOFORM 3).
RC   TISSUE=Fetal brain;
RA   Kimura Y., Saya H., Nakao M.;
RT   "Cloning and identification of human Unph-2.";
RL   Submitted (JUL-1997) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   IDENTIFICATION (ISOFORM 2), AND CATALYTIC ACTIVITY.
RX   PubMed=10444327; DOI=10.1006/geno.1999.5879;
RA   Baker R.T., Wang X.-W., Woollatt E., White J.A., Sutherland G.R.;
RT   "Identification, functional characterization, and chromosomal
RT   localization of USP15, a novel human ubiquitin-specific protease
RT   related to the UNP oncoprotein, and a systematic nomenclature for
RT   human ubiquitin-specific proteases.";
RL   Genomics 59:264-274(1999).
RN   [11]
RP   ALTERNATIVE SPLICING (ISOFORMS 1 AND 2).
RX   PubMed=12532266; DOI=10.1007/s00335-002-3035-0;
RA   Angelats C., Wang X.-W., Jermiin L.S., Copeland N.G., Jenkins N.A.,
RA   Baker R.T.;
RT   "Isolation and characterization of the mouse ubiquitin-specific
RT   protease Usp15.";
RL   Mamm. Genome 14:31-46(2003).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF CYS-812, IDENTIFICATION
RP   IN A COMPLEX WITH THE COP9 SIGNALOSOME, PHOSPHORYLATION, AND
RP   UBIQUITINATION.
RX   PubMed=16005295; DOI=10.1016/j.cub.2005.05.059;
RA   Hetfeld B.K., Helfrich A., Kapelari B., Scheel H., Hofmann K.,
RA   Guterman A., Glickman M., Schade R., Kloetzel P.M., Dubiel W.;
RT   "The zinc finger of the CSN-associated deubiquitinating enzyme USP15
RT   is essential to rescue the E3 ligase Rbx1.";
RL   Curr. Biol. 15:1217-1221(2005).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   FUNCTION.
RX   PubMed=17318178; DOI=10.1038/sj.emboj.7601600;
RA   Schweitzer K., Bozko P.M., Dubiel W., Naumann M.;
RT   "CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha.";
RL   EMBO J. 26:1532-1541(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229; SER-961 AND
RP   SER-965, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   FUNCTION.
RX   PubMed=19826004; DOI=10.1074/jbc.M109.037952;
RA   Cayli S., Klug J., Chapiro J., Frohlich S., Krasteva G., Orel L.,
RA   Meinhardt A.;
RT   "COP9 signalosome interacts ATP-dependently with p97/valosin-
RT   containing protein (VCP) and controls the ubiquitination status of
RT   proteins bound to p97/VCP.";
RL   J. Biol. Chem. 284:34944-34953(2009).
RN   [18]
RP   FUNCTION, AND MUTAGENESIS OF CYS-812.
RX   PubMed=19576224; DOI=10.1016/j.jmb.2009.06.066;
RA   Huang X., Langelotz C., Hetfeld-Pechoc B.K., Schwenk W., Dubiel W.;
RT   "The COP9 signalosome mediates beta-catenin degradation by
RT   deneddylation and blocks adenomatous polyposis coli destruction via
RT   USP15.";
RL   J. Mol. Biol. 391:691-702(2009).
RN   [19]
RP   FUNCTION, MUTAGENESIS OF CYS-298, AND INTERACTION WITH HUMAN
RP   PAPILLOMAVIRUS TYPE 16 PROTEIN E6.
RX   PubMed=19553310; DOI=10.1128/JVI.00605-09;
RA   Vos R.M., Altreuter J., White E.A., Howley P.M.;
RT   "The ubiquitin-specific peptidase USP15 regulates human papillomavirus
RT   type 16 E6 protein stability.";
RL   J. Virol. 83:8885-8892(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229; SER-242; SER-961
RP   AND SER-965, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   SMAD1; SMAD2 AND SMAD3, AND MUTAGENESIS OF CYS-298.
RX   PubMed=21947082; DOI=10.1038/ncb2346;
RA   Inui M., Manfrin A., Mamidi A., Martello G., Morsut L., Soligo S.,
RA   Enzo E., Moro S., Polo S., Dupont S., Cordenonsi M., Piccolo S.;
RT   "USP15 is a deubiquitylating enzyme for receptor-activated SMADs.";
RL   Nat. Cell Biol. 13:1368-1375(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [26]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH TGFBR1 AND SMAD7, AND
RP   MUTAGENESIS OF CYS-298.
RX   PubMed=22344298; DOI=10.1038/nm.2619;
RA   Eichhorn P.J., Rodon L., Gonzalez-Junca A., Dirac A., Gili M.,
RA   Martinez-Saez E., Aura C., Barba I., Peg V., Prat A., Cuartas I.,
RA   Jimenez J., Garcia-Dorado D., Sahuquillo J., Bernards R., Baselga J.,
RA   Seoane J.;
RT   "USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through
RT   the activation of TGF-beta signaling in glioblastoma.";
RL   Nat. Med. 18:429-435(2012).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-226; SER-229 AND
RP   SER-242, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   FUNCTION, INTERACTION WITH RNF20; RNF40 AND SART3, REGION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=24526689; DOI=10.1074/jbc.M114.551754;
RA   Long L., Thelen J.P., Furgason M., Haj-Yahya M., Brik A., Cheng D.,
RA   Peng J., Yao T.;
RT   "The U4/U6 recycling factor SART3 has histone chaperone activity and
RT   associates with USP15 to regulate H2B deubiquitination.";
RL   J. Biol. Chem. 289:8916-8930(2014).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   STRUCTURE BY NMR OF 1-120.
RX   PubMed=16298993; DOI=10.1074/jbc.M510993200;
RA   de Jong R.N., Ab E., Diercks T., Truffault V., Danieels M.,
RA   Kaptein R., Folkers G.E.;
RT   "Solution structure of the human ubiquitin-specific protease 15 DUSP
RT   domain.";
RL   J. Biol. Chem. 281:5026-5031(2006).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 1-222.
RX   PubMed=21848306; DOI=10.1021/bi200726e;
RA   Harper S., Besong T.M., Emsley J., Scott D.J., Dreveny I.;
RT   "Structure of the USP15 N-terminal domains: a beta-hairpin mediates
RT   close association between the DUSP and UBL domains.";
RL   Biochemistry 50:7995-8004(2011).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-223.
RX   PubMed=22001210; DOI=10.1016/j.febslet.2011.09.040;
RA   Elliott P.R., Liu H., Pastok M.W., Grossmann G.J., Rigden D.J.,
RA   Clague M.J., Urbe S., Barsukov I.L.;
RT   "Structural variability of the ubiquitin specific protease DUSP-UBL
RT   double domains.";
RL   FEBS Lett. 585:3385-3390(2011).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 1-133.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the human ubiquitin-specific protease 15 DUSP
RT   domain.";
RL   Submitted (APR-2010) to the PDB data bank.
CC   -!- FUNCTION: Hydrolase that removes conjugated ubiquitin from target
CC       proteins and regulates various pathways such as the TGF-beta
CC       receptor signaling and NF-kappa-B pathways. Acts as a key
CC       regulator of TGF-beta receptor signaling pathway, but the precise
CC       mechanism is still unclear: according to a report, acts by
CC       promoting deubiquitination of monoubiquitinated R-SMADs (SMAD1,
CC       SMAD2 and/or SMAD3), thereby alleviating inhibition of R-SMADs and
CC       promoting activation of TGF-beta target genes (PubMed:21947082).
CC       According to another reports, regulates the TGF-beta receptor
CC       signaling pathway by mediating deubiquitination and stabilization
CC       of TGFBR1, leading to an enhanced TGF-beta signal
CC       (PubMed:22344298). Able to mediate deubiquitination of
CC       monoubiquitinated substrates as well as 'Lys-48'-linked
CC       polyubiquitin chains, protecting them against proteasomal
CC       degradation. May also regulate gene expression and/or DNA repair
CC       through the deubiquitination of histone H2B (PubMed:24526689).
CC       Acts as an associated component of COP9 signalosome complex (CSN)
CC       and regulates different pathways via this association: regulates
CC       NF-kappa-B by mediating deubiquitination of NFKBIA and
CC       deubiquitinates substrates bound to VCP. Protects APC and human
CC       papillomavirus type 16 protein E6 against degradation via the
CC       ubiquitin proteasome pathway. {ECO:0000269|PubMed:16005295,
CC       ECO:0000269|PubMed:17318178, ECO:0000269|PubMed:19553310,
CC       ECO:0000269|PubMed:19576224, ECO:0000269|PubMed:19826004,
CC       ECO:0000269|PubMed:21947082, ECO:0000269|PubMed:22344298,
CC       ECO:0000269|PubMed:24526689}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:10444327, ECO:0000269|PubMed:16005295,
CC       ECO:0000269|PubMed:21947082, ECO:0000269|PubMed:22344298}.
CC   -!- SUBUNIT: A homodimer structure has been reported; however it is
CC       unclear whether the protein form a homodimer in vivo
CC       (PubMed:22001210). Identified in a complex with the COP9
CC       signalosome complex (CSN). Interacts with SMAD1, SMAD2 and SMAD3;
CC       the interaction is direct. Forms a complex with SMURF2 and SMAD7.
CC       Interacts with TGFBR1. Interacts with SART3; the interaction is
CC       direct. May interact with RNF20 and RNF40. Interacts with human
CC       papillomavirus type 16 protein E6. {ECO:0000269|PubMed:16005295,
CC       ECO:0000269|PubMed:19553310, ECO:0000269|PubMed:21947082,
CC       ECO:0000269|PubMed:22001210, ECO:0000269|PubMed:22344298,
CC       ECO:0000269|PubMed:24526689}.
CC   -!- INTERACTION:
CC       Self; NbExp=5; IntAct=EBI-1043104, EBI-1043104;
CC       Q9H257:CARD9; NbExp=3; IntAct=EBI-1043104, EBI-751319;
CC       Q2TAC2:CCDC57; NbExp=3; IntAct=EBI-1043104, EBI-2808286;
CC       Q9Y6D9:MAD1L1; NbExp=3; IntAct=EBI-1043104, EBI-742610;
CC       Q96EA4:SPDL1; NbExp=3; IntAct=EBI-1043104, EBI-715381;
CC       P19474:TRIM21; NbExp=3; IntAct=EBI-1043104, EBI-81290;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21947082,
CC       ECO:0000269|PubMed:24526689}. Nucleus
CC       {ECO:0000269|PubMed:21947082, ECO:0000269|PubMed:24526689}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Y4E8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y4E8-2; Sequence=VSP_005261;
CC       Name=3;
CC         IsoId=Q9Y4E8-3; Sequence=VSP_005260;
CC       Name=4;
CC         IsoId=Q9Y4E8-4; Sequence=VSP_045165, VSP_045166;
CC   -!- TISSUE SPECIFICITY: Expressed in skeletal muscle, kidney, heart,
CC       placenta, liver, thymus, lung, and ovary, with little or no
CC       expression in other tissues.
CC   -!- PTM: Phosphorylated. Phosphorylation protects against
CC       ubiquitination and subsequent degradation by the proteasome.
CC       {ECO:0000269|PubMed:16005295}.
CC   -!- PTM: Ubiquitinated, leading to degradation by the proteasome.
CC       {ECO:0000269|PubMed:16005295}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/USP15ID44585ch12q14.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF106069; AAD52099.1; -; mRNA.
DR   EMBL; AB011101; BAA25455.2; -; mRNA.
DR   EMBL; AF153604; AAD41086.1; -; mRNA.
DR   EMBL; AK023703; BAB14648.1; -; mRNA.
DR   EMBL; AK292337; BAF85026.1; -; mRNA.
DR   EMBL; AC048342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079035; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC117370; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC020688; AAH20688.1; -; mRNA.
DR   EMBL; BC063454; AAH63454.1; -; mRNA.
DR   EMBL; BC125123; AAI25124.1; -; mRNA.
DR   EMBL; AF013990; AAG28973.1; -; mRNA.
DR   CCDS; CCDS58250.1; -. [Q9Y4E8-4]
DR   CCDS; CCDS58251.1; -. [Q9Y4E8-1]
DR   CCDS; CCDS8963.1; -. [Q9Y4E8-2]
DR   RefSeq; NP_001239007.1; NM_001252078.1. [Q9Y4E8-1]
DR   RefSeq; NP_001239008.1; NM_001252079.1. [Q9Y4E8-4]
DR   RefSeq; NP_006304.1; NM_006313.2. [Q9Y4E8-2]
DR   UniGene; Hs.434951; -.
DR   PDB; 1W6V; NMR; -; A=1-120.
DR   PDB; 3LMN; X-ray; 2.15 A; A/B=1-133.
DR   PDB; 3PPA; X-ray; 2.35 A; A=6-223.
DR   PDB; 3PV1; X-ray; 2.60 A; A/B=1-223.
DR   PDB; 3T9L; X-ray; 1.50 A; A=1-222.
DR   PDB; 4A3O; X-ray; 2.20 A; A/B=4-223.
DR   PDB; 4A3P; X-ray; 1.40 A; A=6-223.
DR   PDB; 5JJW; X-ray; 3.01 A; B=1-223.
DR   PDBsum; 1W6V; -.
DR   PDBsum; 3LMN; -.
DR   PDBsum; 3PPA; -.
DR   PDBsum; 3PV1; -.
DR   PDBsum; 3T9L; -.
DR   PDBsum; 4A3O; -.
DR   PDBsum; 4A3P; -.
DR   PDBsum; 5JJW; -.
DR   ProteinModelPortal; Q9Y4E8; -.
DR   SMR; Q9Y4E8; -.
DR   BioGrid; 115283; 151.
DR   DIP; DIP-50239N; -.
DR   IntAct; Q9Y4E8; 59.
DR   MINT; MINT-4542165; -.
DR   STRING; 9606.ENSP00000258123; -.
DR   MEROPS; C19.022; -.
DR   iPTMnet; Q9Y4E8; -.
DR   PhosphoSitePlus; Q9Y4E8; -.
DR   BioMuta; USP15; -.
DR   DMDM; 28381406; -.
DR   EPD; Q9Y4E8; -.
DR   PaxDb; Q9Y4E8; -.
DR   PeptideAtlas; Q9Y4E8; -.
DR   PRIDE; Q9Y4E8; -.
DR   DNASU; 9958; -.
DR   Ensembl; ENST00000280377; ENSP00000280377; ENSG00000135655. [Q9Y4E8-1]
DR   Ensembl; ENST00000312635; ENSP00000309240; ENSG00000135655. [Q9Y4E8-4]
DR   Ensembl; ENST00000353364; ENSP00000258123; ENSG00000135655. [Q9Y4E8-2]
DR   GeneID; 9958; -.
DR   KEGG; hsa:9958; -.
DR   UCSC; uc001sra.4; human. [Q9Y4E8-1]
DR   CTD; 9958; -.
DR   DisGeNET; 9958; -.
DR   GeneCards; MIR6125; -.
DR   GeneCards; USP15; -.
DR   H-InvDB; HIX0010773; -.
DR   HGNC; HGNC:12613; USP15.
DR   HPA; HPA006237; -.
DR   HPA; HPA006428; -.
DR   HPA; HPA071014; -.
DR   MIM; 604731; gene.
DR   neXtProt; NX_Q9Y4E8; -.
DR   OpenTargets; ENSG00000135655; -.
DR   PharmGKB; PA37239; -.
DR   eggNOG; KOG1870; Eukaryota.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00670000097750; -.
DR   HOGENOM; HOG000264375; -.
DR   HOVERGEN; HBG000864; -.
DR   InParanoid; Q9Y4E8; -.
DR   KO; K21343; -.
DR   OMA; FEIAINR; -.
DR   OrthoDB; EOG091G0157; -.
DR   PhylomeDB; Q9Y4E8; -.
DR   TreeFam; TF106276; -.
DR   Reactome; R-HSA-2173788; Downregulation of TGF-beta receptor signaling.
DR   Reactome; R-HSA-5689603; UCH proteinases.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP15; human.
DR   EvolutionaryTrace; Q9Y4E8; -.
DR   GeneWiki; USP15; -.
DR   GenomeRNAi; 9958; -.
DR   PRO; PR:Q9Y4E8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000135655; -.
DR   CleanEx; HS_USP15; -.
DR   ExpressionAtlas; Q9Y4E8; baseline and differential.
DR   Genevisible; Q9Y4E8; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IMP:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046332; F:SMAD binding; IPI:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0005160; F:transforming growth factor beta receptor binding; IPI:UniProtKB.
DR   GO; GO:0061649; F:ubiquitinated histone binding; IDA:UniProtKB.
DR   GO; GO:0030509; P:BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0035616; P:histone H2B conserved C-terminal lysine deubiquitination; IDA:UniProtKB.
DR   GO; GO:0035520; P:monoubiquitinated protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0060389; P:pathway-restricted SMAD protein phosphorylation; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.2230.10; -; 1.
DR   InterPro; IPR006615; Pept_C19_DUSP.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR013792; RNA3'P_cycl/enolpyr_Trfase_a/b.
DR   InterPro; IPR028135; Ub_USP-typ.
DR   InterPro; IPR029071; Ubiquitin-rel_dom.
DR   InterPro; IPR029346; USP_C.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   Pfam; PF06337; DUSP; 1.
DR   Pfam; PF14836; Ubiquitin_3; 1.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF14533; USP7_C2; 1.
DR   SMART; SM00695; DUSP; 1.
DR   SUPFAM; SSF143791; SSF143791; 1.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   SUPFAM; SSF55205; SSF55205; 1.
DR   PROSITE; PS51283; DUSP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Hydrolase; Nucleus;
KW   Phosphoprotein; Protease; Reference proteome; Thiol protease;
KW   Ubl conjugation; Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.8}.
FT   CHAIN         2    981       Ubiquitin carboxyl-terminal hydrolase 15.
FT                                /FTId=PRO_0000080641.
FT   DOMAIN        7    118       DUSP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00613}.
FT   DOMAIN      289    933       USP.
FT   REGION        2    223       Mediates interaction with SART3.
FT                                {ECO:0000269|PubMed:24526689}.
FT   ACT_SITE    298    298       Nucleophile.
FT   ACT_SITE    891    891       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.8}.
FT   MOD_RES     226    226       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     229    229       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     602    602       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q8R5H1}.
FT   MOD_RES     961    961       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     965    965       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231}.
FT   VAR_SEQ     217    256       DGTWPRGPSTPKSPGASNFSTLPKISPSSLSNNYNNMNNR
FT                                -> QKNEDGTWPRGPSTP (in isoform 3).
FT                                {ECO:0000303|Ref.9}.
FT                                /FTId=VSP_005260.
FT   VAR_SEQ     228    256       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9628581,
FT                                ECO:0000303|Ref.1}.
FT                                /FTId=VSP_005261.
FT   VAR_SEQ     229    235       SPGASNF -> KPLEQSC (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045165.
FT   VAR_SEQ     236    981       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_045166.
FT   MUTAGEN     298    298       C->A: Loss of enzyme activity.
FT                                {ECO:0000269|PubMed:19553310,
FT                                ECO:0000269|PubMed:21947082,
FT                                ECO:0000269|PubMed:22344298}.
FT   MUTAGEN     812    812       C->A: Loss of activity towards
FT                                polyubiquitin.
FT                                {ECO:0000269|PubMed:16005295,
FT                                ECO:0000269|PubMed:19576224}.
FT   CONFLICT    559    559       T -> A (in Ref. 9; AAG28973).
FT                                {ECO:0000305}.
FT   CONFLICT    747    747       S -> F (in Ref. 7; AAI25124).
FT                                {ECO:0000305}.
FT   CONFLICT    968    968       N -> H (in Ref. 9; AAG28973).
FT                                {ECO:0000305}.
FT   STRAND        4      6       {ECO:0000244|PDB:1W6V}.
FT   HELIX         9     19       {ECO:0000244|PDB:4A3P}.
FT   STRAND       29     34       {ECO:0000244|PDB:4A3P}.
FT   HELIX        35     45       {ECO:0000244|PDB:4A3P}.
FT   TURN         46     48       {ECO:0000244|PDB:3T9L}.
FT   TURN         53     56       {ECO:0000244|PDB:4A3P}.
FT   HELIX        58     60       {ECO:0000244|PDB:4A3P}.
FT   HELIX        68     70       {ECO:0000244|PDB:4A3P}.
FT   STRAND       73     76       {ECO:0000244|PDB:3T9L}.
FT   TURN         86     88       {ECO:0000244|PDB:4A3P}.
FT   STRAND       89     93       {ECO:0000244|PDB:4A3P}.
FT   HELIX        94    104       {ECO:0000244|PDB:4A3P}.
FT   STRAND      114    120       {ECO:0000244|PDB:4A3P}.
FT   STRAND      122    124       {ECO:0000244|PDB:5JJW}.
FT   STRAND      127    129       {ECO:0000244|PDB:4A3P}.
FT   STRAND      134    140       {ECO:0000244|PDB:4A3P}.
FT   STRAND      143    152       {ECO:0000244|PDB:4A3P}.
FT   HELIX       158    168       {ECO:0000244|PDB:4A3P}.
FT   STRAND      173    175       {ECO:0000244|PDB:4A3O}.
FT   STRAND      177    184       {ECO:0000244|PDB:4A3P}.
FT   STRAND      187    190       {ECO:0000244|PDB:4A3P}.
FT   HELIX       198    201       {ECO:0000244|PDB:4A3P}.
FT   STRAND      208    213       {ECO:0000244|PDB:4A3P}.
SQ   SEQUENCE   981 AA;  112419 MW;  E81FEB9DE57F7089 CRC64;
     MAEGGAADLD TQRSDIATLL KTSLRKGDTW YLVDSRWFKQ WKKYVGFDSW DKYQMGDQNV
     YPGPIDNSGL LKDGDAQSLK EHLIDELDYI LLPTEGWNKL VSWYTLMEGQ EPIARKVVEQ
     GMFVKHCKVE VYLTELKLCE NGNMNNVVTR RFSKADTIDT IEKEIRKIFS IPDEKETRLW
     NKYMSNTFEP LNKPDSTIQD AGLYQGQVLV IEQKNEDGTW PRGPSTPKSP GASNFSTLPK
     ISPSSLSNNY NNMNNRNVKN SNYCLPSYTA YKNYDYSEPG RNNEQPGLCG LSNLGNTCFM
     NSAIQCLSNT PPLTEYFLND KYQEELNFDN PLGMRGEIAK SYAELIKQMW SGKFSYVTPR
     AFKTQVGRFA PQFSGYQQQD CQELLAFLLD GLHEDLNRIR KKPYIQLKDA DGRPDKVVAE
     EAWENHLKRN DSIIVDIFHG LFKSTLVCPE CAKISVTFDP FCYLTLPLPM KKERTLEVYL
     VRMDPLTKPM QYKVVVPKIG NILDLCTALS ALSGIPADKM IVTDIYNHRF HRIFAMDENL
     SSIMERDDIY VFEININRTE DTEHVIIPVC LREKFRHSSY THHTGSSLFG QPFLMAVPRN
     NTEDKLYNLL LLRMCRYVKI STETEETEGS LHCCKDQNIN GNGPNGIHEE GSPSEMETDE
     PDDESSQDQE LPSENENSQS EDSVGGDNDS ENGLCTEDTC KGQLTGHKKR LFTFQFNNLG
     NTDINYIKDD TRHIRFDDRQ LRLDERSFLA LDWDPDLKKR YFDENAAEDF EKHESVEYKP
     PKKPFVKLKD CIELFTTKEK LGAEDPWYCP NCKEHQQATK KLDLWSLPPV LVVHLKRFSY
     SRYMRDKLDT LVDFPINDLD MSEFLINPNA GPCRYNLIAV SNHYGGMGGG HYTAFAKNKD
     DGKWYYFDDS SVSTASEDQI VSKAAYVLFY QRQDTFSGTG FFPLDRETKG ASAATGIPLE
     SDEDSNDNDN DIENENCMHT N
//
